ASCO 2022 | Ascentage Pharma Releases Updated Data Demonstrating Lisaftoclax’s (APG-2575) Therapeutic Potential in Patients with R/R CLL/SLL
June 8, 2022 — 08:00 CST
This Data Is Locked!
This area is available only to Subscribers.
SUZHOU, China and ROCKVILLE, Md., June 8, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
